5:01 PM ET
8-K
Nasdaq/NYSE Compliance Notice
Moleculin Biotech Nasdaq/NYSE Compliance Notice
Moleculin Biotech received a Staff Determination Letter from Nasdaq notifying the company that its common stock failed to maintain the $1.00 minimum bid price for 30 consecutive business days. Because the company already performed a reverse stock split within the last year, it is ineligible for the standard 180-day grace period and faces immediate delisting unless it successfully appeals to the Nasdaq Hearings Panel.
- Counterparty
- The Nasdaq Stock Market LLC